Validity of the Patient-Reported Clinical Global Impression of Change as a Measure of Treatment Response in Men with Premature Ejaculation

被引:27
|
作者
Althof, Stanley E. [1 ]
Brock, Gerald B. [2 ]
Rosen, Raymond C. [3 ]
Rowland, David L. [4 ]
Aquilina, Joseph W. [5 ]
Rothman, Margaret [6 ]
Tesfaye, Fisseha [5 ]
Bull, Scott [5 ]
机构
[1] Case Western Reserve Univ, Sch Med, Ctr Marital & Sexual Hlth S Florida, W Palm Beach, FL 33401 USA
[2] St Josephs Hlth Ctr, Dept Surg, Div Urol, London, ON, Canada
[3] New England Res Inst, Watertown, MA 02172 USA
[4] Valparaiso Univ, Valparaiso, IN 46383 USA
[5] Johnson & Johnson Pharmaceut Res & Dev LLC, Raritan, NJ USA
[6] Johnson & Johnson Pharmaceut Serv LLC, Raritan, NJ USA
基金
美国国家卫生研究院;
关键词
Premature Ejaculation; Sexual Dysfunction; Clinical Global Impression of Change; Treatment; Dapoxetine; OUTCOME MEASURES; BEHAVIOR CHANGES; VALIDATION; QUESTIONNAIRE; SATISFACTION; DEFINITION; DEMENTIA; TRIALS; WOMEN; SCALE;
D O I
10.1111/j.1743-6109.2010.01793.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction. The Clinical Global Impression of Change (CGIC) measures have high utility in clinical practice. However, it is unknown whether the CGIC is valued for assessing premature ejaculation (PE) symptoms and/or the relationship between CGIC and other validated PE patient-reported measures. Aim. The study aims to assess the validity of the patient-reported CGIC measure in men with PE and to examine the relationship between CGIC ratings and assessments of control, satisfaction, personal distress, and interpersonal difficulty. Methods. Data from a randomized, double-blind, 24-week phase 3 trial in 1,162 men with PE who received dapoxetine (30 mg or 60 mg) or placebo on demand provided the basis for the analysis. Patients were >= 18 years, in a stable monogamous relationship for >= 6 months, met the Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition-Text Revision criteria for PE for >= 6 months, and had an intravaginal ejaculatory latency time (IELT) < 2 minutes in >= 75% of intercourse episodes. Main Outcome Measures. The CGIC asked patients to rate improvement or worsening of their PE compared with the start of the study using a 7-point response scale; other patient-reported measures were control over ejaculation, satisfaction with sexual intercourse, interpersonal difficulty, and personal distress related to ejaculation. Stopwatch-measured IELT was recorded. Associations between CGIC and change in other measures at study end point were assessed. Results. The magnitude of IELT increased for each category of improvement on the CGIC: 1.63, 4.03, and 7.15 minutes for slightly better, better, and much better, respectively. Higher CGIC ratings were correlated with greater improvement in control (r = 0.73), satisfaction (r = 0.62), greater reduction in distress (r = -0.52), and interpersonal difficulty (r = -0.39). Total variance accounted for was 57.4%: control (48.7%), satisfaction (4.5%), IELT (2.8%), and distress (1.15%). Conclusions. The analyses support the validity of the CGIC measure in men with PE. The CGIC can provide clinicians in practice with a valid and brief outcome assessment of their patient's condition. Althof SE, Brock GB, Rosen RC, Rowland DL, Aquilina JW, Rothman M, Tesfaye F, and Bull S. Validity of the patient-reported clinical global impression of change as a measure of treatment response in men with premature ejaculation. J Sex Med 2010;7:2243-2252.
引用
收藏
页码:2243 / 2252
页数:10
相关论文
共 50 条
  • [1] On-demand Modafinil Improves Ejaculation Time and Patient-reported Outcomes in Men With Lifelong Premature Ejaculation
    Tuken, Murat
    Kiremit, Murat Can
    Serefoglu, Ege Can
    UROLOGY, 2016, 94 : 139 - 142
  • [2] An Internally Validated Nomogram for Predicting the Likelihood of Improvement of Clinical Global Impression in Patients With Lifelong Premature Ejaculation Treated With Dapoxetine
    Hou, Guangdong
    Gao, Ming
    Zhang, Lei
    Dun, Xinlong
    Zheng, Yu
    Wang, Fuli
    Yan, Fei
    Zheng, Wanxiang
    Yin, Chuanmin
    Yuan, Jiarui
    Zhang, Geng
    Meng, Ping
    Jannini, Emmanuele A.
    Yuan, Jianlin
    JOURNAL OF SEXUAL MEDICINE, 2020, 17 (12) : 2341 - 2350
  • [3] The Responsiveness, Content Validity, and Convergent Validity of the Measure Yourself Concerns and Wellbeing (MYCaW) Patient-Reported Outcome Measure
    Jolliffe, Rachel
    Seers, Helen
    Jackson, Sarah
    Caro, Elena
    Weeks, Laura
    Polley, Marie J.
    INTEGRATIVE CANCER THERAPIES, 2015, 14 (01) : 26 - 34
  • [4] Calculate Patient-Reported Scores as Recommended so as Not to Threaten the Validity of the Measure: Response
    Sgroi, Mirco
    Kocak, Semra
    Reichel, Heiko
    Kappe, Thomas
    ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE, 2018, 6 (12)
  • [5] Reliability, Validity, and Efficiency of an Item Response Theory-Based Balance Confidence Patient-Reported Outcome Measure
    Deutscher, Daniel
    Kallen, Michael A.
    Werneke, Mark W.
    Mioduski, Jerome E.
    Hayes, Deanna
    PHYSICAL THERAPY, 2023, 103 (07):
  • [6] Validity and Sensitivity to Change of Patient-Reported Pain and Disability Measures for Elbow Pathologies
    Vincent, Joshua I.
    Macdermid, Joy C.
    King, Graham J. W.
    Grewal, Ruby
    JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY, 2013, 43 (04) : 263 - 274
  • [7] An Exploration of Emotional Response to Erotic Stimulation in Men with Premature Ejaculation: Effects of Treatment with Clomipramine
    David L. Rowland
    Wendi L. Tai
    A. Koos Slob
    Archives of Sexual Behavior, 2003, 32 : 145 - 153
  • [8] An exploration of emotional response to erotic stimulation in men with premature ejaculation: Effects of treatment with clomipramine
    Rowland, DL
    Tai, WL
    Slob, AK
    ARCHIVES OF SEXUAL BEHAVIOR, 2003, 32 (02) : 145 - 153
  • [9] The Role of Patient-Reported Outcomes to Measure Treatment Satisfaction in Drug Development
    Navas, Carolina
    Minton, Alexandra Palmer
    Rodriguez-Leboeuf, Ana Maria
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2024, 17 (06) : 603 - 617
  • [10] Known-groups validity and responsiveness to change of the Patient Experience with Treatment and Self-management (PETS vs. 2.0): a patient-reported measure of treatment burden
    David T. Eton
    Minji K. Lee
    Jennifer L. St. Sauver
    Roger T. Anderson
    Quality of Life Research, 2020, 29 : 3143 - 3154